Work

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.

Year: 2002

Type: article

Study design: Observational Study

Source: PubMed

Authors: Colleen S Sinclair, Camilo Adem, Ali Naderi, Cheryl L Soderberg, Michele Johnson, Kangjian Wu, Linda Wadum, Vicki L Couch, Thomas A Sellers, Daniel Schaid, Jeffrey Slezak, Zach Fredericksen, James N Ingle, Lynn Hartmann, Robert B Jenkins, Fergus J Couch

Institution: Mayo Clinic

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: EPIDEMIOLOGIC AND GENETIC STUDIES OF BREAST CANCER, PROPHYLCTIC MASTECTOMY IN HEREDITARY BREAST CANCER, BIOLOGY OF CANCER: A PREDOCTORAL TRAINING PROGRAM, Characterization of the Chromosome 17q23 Amplicon

OpenAlex ID: W1778321542

FWCI: 2.652

Cites: 14

Cited by: 84

Related to: 10